Search research articles
Contact Us
Filters
Showing results (51-60 of 98) with videos related to
Page
of 10
Sort By:
JAMA Network Open
|
September 29, 2020
Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy
Chelsea C Pinnix, Jillian R Gunther, Penny Fang, et al.
Leukemia & Lymphoma
|
August 9, 2021
Preclinical and phase I studies of KA2237, a selective and potent inhibitor of PI3K β/δ in relapsed refractory B cell lymphoma
Loretta J Nastoupil, Sattva S Neelapu, Richard Eric Davis, et al.
Nature Reviews. Clinical Oncology
|
September 20, 2017
Chimeric antigen receptor T-cell therapy - assessment and management of toxicities
Sattva S Neelapu, Sudhakar Tummala, Partow Kebriaei, et al.
Head & Neck
|
June 1, 2018
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma
Chelsea C Pinnix, Bouthaina S Dabaja, Sarah A Milgrom, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 10, 2026
A circulating protein signature for predicting severe immune-related adverse events following CAR T-cell therapy in relapsed/refractory lymphoma
Ehsan Irajizad, Johannes F Fahrmann, Hiroyuki Katayama, et al.
Head & Neck
|
April 4, 2017
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma
Chelsea C Pinnix, Bouthaina S Dabaja, Sarah A Milgrom, et al.
American Journal of Hematology
|
February 21, 2019
Frontline antibiotic therapy for early-stage Helicobacter pylori-negative gastric MALT lymphoma
Paolo Strati, Seung Tae Lee, Purnima Teegavarupu, et al.
The Oncologist
|
April 15, 2017
Phase II Study of Bortezomib in Combination with Cyclophosphamide and Rituximab for Relapsed or Refractory Mantle Cell Lymphoma
Hun Ju Lee, Jorge E Romaguera, Lei Feng, et al.
Blood Advances
|
June 27, 2020
Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma
Chelsea C Pinnix, Jillian R Gunther, Bouthaina S Dabaja, et al.
Advances in Radiation Oncology
|
November 18, 2024
Early-Stage Extranodal NK/T-Cell Lymphoma, Nasal Type: A Role for Elective Nodal Irradiation?
Penny Fang, Sonal S Noticewala, Susan Y Wu, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 98) with videos related to
Sort By:
Page
of 10
JAMA Network Open
|
September 29, 2020
Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy
Chelsea C Pinnix, Jillian R Gunther, Penny Fang, et al.
Leukemia & Lymphoma
|
August 9, 2021
Preclinical and phase I studies of KA2237, a selective and potent inhibitor of PI3K β/δ in relapsed refractory B cell lymphoma
Loretta J Nastoupil, Sattva S Neelapu, Richard Eric Davis, et al.
Nature Reviews. Clinical Oncology
|
September 20, 2017
Chimeric antigen receptor T-cell therapy - assessment and management of toxicities
Sattva S Neelapu, Sudhakar Tummala, Partow Kebriaei, et al.
Head & Neck
|
June 1, 2018
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma
Chelsea C Pinnix, Bouthaina S Dabaja, Sarah A Milgrom, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 10, 2026
A circulating protein signature for predicting severe immune-related adverse events following CAR T-cell therapy in relapsed/refractory lymphoma
Ehsan Irajizad, Johannes F Fahrmann, Hiroyuki Katayama, et al.
Head & Neck
|
April 4, 2017
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma
Chelsea C Pinnix, Bouthaina S Dabaja, Sarah A Milgrom, et al.
American Journal of Hematology
|
February 21, 2019
Frontline antibiotic therapy for early-stage Helicobacter pylori-negative gastric MALT lymphoma
Paolo Strati, Seung Tae Lee, Purnima Teegavarupu, et al.
The Oncologist
|
April 15, 2017
Phase II Study of Bortezomib in Combination with Cyclophosphamide and Rituximab for Relapsed or Refractory Mantle Cell Lymphoma
Hun Ju Lee, Jorge E Romaguera, Lei Feng, et al.
Blood Advances
|
June 27, 2020
Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma
Chelsea C Pinnix, Jillian R Gunther, Bouthaina S Dabaja, et al.
Advances in Radiation Oncology
|
November 18, 2024
Early-Stage Extranodal NK/T-Cell Lymphoma, Nasal Type: A Role for Elective Nodal Irradiation?
Penny Fang, Sonal S Noticewala, Susan Y Wu, et al.
Page
of 10